活血化瘀类中药注射剂临床应用合理性分析

An Analysis of Clinical Application Rationality of TCM Injection for Blood-activating Stasis-removing

目的:分析某医院活血化瘀类中药注射剂的应用状况,为临床合理用药提供参考。方法:抽取某医院2018年1~12月期间使用活血化瘀类中药注射剂住院患者病历,对活血化瘀类中药注射剂的临床应用进行分析。结果:765份病历中活血化瘀类中药注射剂不合理现象包括:联用未冲管占59.87%(458/765)、适应症不合理占21.44%(164/765)、配伍禁忌占10.72%(82/765)、超疗程用药占7.45%(57/765)、重复用药占5.62%(43/765)、溶媒选择错误占3.14%(24/765)。结论:该院活血化瘀类中药注射剂临床应用有待进一步提高,应在中医药理论指导下使用,以确保临床合理用药。

Objective:To provide the reference for clinical rational use by analyzing the application status of TCM injections for blood-activating stasis-removing in a hospital.Methods:Clinical application of TCM injections for blood-activating stasis-removing was analyzed after selecting the medical records of the inpatients who were given TCM injections for blood-activating stasis-removing from January to December of 2018 in a hospital.Results:Unreasonable phenomenon of 765 cases of using TCM injections for blood-activating stasis-removing contained:no flushing pipe in drug combination 59.87%(458/765),unreasonable indication 21.44%(164/765),incompatibility 10.72%(82/765),themedication beyond the course 7.45%(57/765),repeatmedication 5.62%(43/765),wrong selection of solvent 3.14%(24/765).Conclusion:Clinical application of TCM injections for blood-activating stasis-removing in the hospital needs to be further improved,it should be used under the guidance of TCM theory to ensure rational clinical application.